PMPRB releases Generic360 report

On February 6 2018 the Patented Medicine Prices Review Board (PMPRB) announced the publication of the most recent edition of its series of reports on generic drug pricing. Generics360 reports on the latest trends in Canadian generic drug sales, utilization and pricing within an international context. The main international focus was on Canada’s price reference countries (France, Germany, Italy, Sweden, Switzerland, the UK and the US).

The report examines the prices of 605 leading generic drugs and indicates that average generic drug prices in Canada fell from 63% to 33% of their brand-name counterparts between the first quarter of 2010 and the fourth quarter of 2016.

See the report here.

Tagged with

Published 5. April 2018 in News Canada